Learn about the global naloxone spray market through The Business Research Company, which provides information on naloxone spray market size, naloxone spray market drivers and restraints, naloxone spray market players, the COVID-19 impact on the naloxone spray market, and more.

The global naloxone spray market size is expected to grow from $351.39 million in 2021 to $432.33 million in 2022 at a compound annual growth rate (CAGR) of 23%. The change in the naloxone spray market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $968.93 million in 2026 at a CAGR of 22.4%.

The increasing prevalence of opioid overdoses will drive the growth of the naloxone spray market.

Request A Sample For The Global Naloxone Spray Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp

The naloxone spray market consists of sales of naloxone spray by entities (organizations, sole traders, and partnerships) which is prefilled with naloxone a needle-free device that is sprayed into one nostril, and requires no assembly. It is used for treating an opioid emergency with symptoms such as problems with breathing and severe sleepiness or inability to respond. Naloxone is a non-scheduled prescription drug, belongs to the class of medications called opiate antagonists, and is used to reverse or prevent the effects of opioid narcotic overdose for drugs such as codeine, fentanyl, morphine, and oxycodone. Naloxone comes as a solution (liquid) to spray into the nose and each naloxone nasal spray contains a single dose of naloxone and should be used only once.

Global naloxone spray market segments include:

By Dosage: 2 mg/Actuation, 4 mg/Actuation

By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the naloxone spray market in 2021.

The increase in product approvals is shaping the naloxone spray market. Major companies manufacturing naloxone sprays are focused on new product approvals to broaden their product portfolios and expand their naloxone spray business.

TBRC’s naloxone spray market report covers:

Major Market Players: Emergent BioSolutions, Pfizer, Teva Pharmaceutical Industries Ltd., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Nasus Pharma, Amphastar Pharmaceuticals, Indivior PLC, Samarth Pharma Pvt. Ltd., Troikaa Pharmaceuticals Ltd., and Neon Laboratories Limited.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Naloxone Spray Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides naloxone spray market overviews, analyzes and forecasts market size, share, naloxone spray market players, naloxone spray market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s naloxone spray market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Drug Delivery Devices Global Market Report 2022

Nasal Splints Global Market Report 2022

ENT Devices Global Market Report 2022

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: